TY - JOUR
T1 - Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)
AU - the JPSC-AD Study Group
AU - Tachibana, Ayumi
AU - Iga, Jun Ichi
AU - Ozaki, Tomoki
AU - Yoshida, Taku
AU - Yoshino, Yuta
AU - Shimizu, Hideaki
AU - Mori, Takaaki
AU - Furuta, Yoshihiko
AU - Shibata, Mao
AU - Ohara, Tomoyuki
AU - Hata, Jun
AU - Taki, Yasuyuki
AU - Mikami, Tatsuya
AU - Maeda, Tetsuya
AU - Ono, Kenjiro
AU - Mimura, Masaru
AU - Nakashima, Kenji
AU - Takebayashi, Minoru
AU - Ninomiya, Toshiharu
AU - Ueno, Shu Ichi
AU - Honda, Takanori
AU - Akiyama, Masato
AU - Nakaji, Shigeyuki
AU - Murashita, Koichi
AU - Sawada, Kaori
AU - Yokoyama, Shintaro
AU - Ishizuka, Naoki
AU - Akasaka, Hiroshi
AU - Terayama, Yasuo
AU - Yonezawa, Hisashi
AU - Takahashi, Junko
AU - Noguchi-Shinohara, Moeko
AU - Iwasa, Kazuo
AU - Yuki-Nozaki, Sohshi
AU - Yamada, Masahito
AU - Bun, Shogyoku
AU - Niimura, Hidehito
AU - Shikimoto, Ryo
AU - Kida, Hisashi
AU - Fukada, Yasuyo
AU - Kowa, Hisanori
AU - Nakano, Toshiya
AU - Wada, Kenji
AU - Kishi, Masafumi
AU - Ishikawa, Tomohisa
AU - Yuki, Seiji
AU - Fukuhara, Ryuji
AU - Koyama, Asuka
AU - Hashimoto, Mamoru
AU - Ikeda, Manabu
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - In recent years, the association between neuroinflammatory markers and dementia, especially Alzheimer’s disease (AD), has attracted much attention. However, the evidence for the relationship between serum-hs-CRP and dementia including AD are inconsistent. Therefore, the relationships of serum high-sensitivity CRP (hs-CRP) with dementia including AD and with regions of interest of brain MRI were investigated. A total of 11,957 community residents aged 65 years or older were recruited in eight sites in Japan (JPSC-AD Study). After applying exclusion criteria, 10,085 participants who underwent blood tests and health-related examinations were analyzed. Then, serum hs-CRP levels were classified according to clinical cutoff values, and odds ratios for the presence of all-cause dementia and its subtypes were calculated for each serum hs-CRP level. In addition, the association between serum hs-CRP and brain volume regions of interest was also examined using analysis of covariance with data from 8614 individuals in the same cohort who underwent brain MRI. After multivariable adjustment, the odds ratios (ORs) for all-cause dementia were 1.04 (95% confidence interval [CI] 0.76–1.43), 1.68 (95%CI 1.08–2.61), and 1.51 (95%CI 1.08–2.11) for 1.0–1.9 mg/L, 2.0–2.9 mg/L, and ≥ 3.0 mg/L, respectively, compared to < 1.0 mg/L, and those for AD were 0.72 (95%CI 0.48–1.08), 1.76 (95%CI 1.08–2.89), and 1.61 (95%CI 1.11–2.35), for 1.0–1.9 mg/L, 2.0–2.9 mg/L, and ≥ 3.0 mg/L, respectively, compared to < 1.0 mg/L. Multivariable-adjusted ORs for all-cause dementia and for AD prevalence increased significantly with increasing serum hs-CRP levels (p for trend < 0.001 and p = 0.001, respectively). In addition, the multivariable-adjusted temporal cortex volume/estimated total intracranial volume ratio decreased significantly with increasing serum hs-CRP levels (< 1.0 mg/L 4.28%, 1.0–1.9 mg/L 4.27%, 2.0–2.9 mg/L 4.29%, ≥ 3.0 mg/L 4.21%; p for trend = 0.004). This study’s results suggest that elevated serum hs-CRP levels are associated with greater risk of presence of dementia, especially AD, and of temporal cortex atrophy in a community-dwelling Japanese older population.
AB - In recent years, the association between neuroinflammatory markers and dementia, especially Alzheimer’s disease (AD), has attracted much attention. However, the evidence for the relationship between serum-hs-CRP and dementia including AD are inconsistent. Therefore, the relationships of serum high-sensitivity CRP (hs-CRP) with dementia including AD and with regions of interest of brain MRI were investigated. A total of 11,957 community residents aged 65 years or older were recruited in eight sites in Japan (JPSC-AD Study). After applying exclusion criteria, 10,085 participants who underwent blood tests and health-related examinations were analyzed. Then, serum hs-CRP levels were classified according to clinical cutoff values, and odds ratios for the presence of all-cause dementia and its subtypes were calculated for each serum hs-CRP level. In addition, the association between serum hs-CRP and brain volume regions of interest was also examined using analysis of covariance with data from 8614 individuals in the same cohort who underwent brain MRI. After multivariable adjustment, the odds ratios (ORs) for all-cause dementia were 1.04 (95% confidence interval [CI] 0.76–1.43), 1.68 (95%CI 1.08–2.61), and 1.51 (95%CI 1.08–2.11) for 1.0–1.9 mg/L, 2.0–2.9 mg/L, and ≥ 3.0 mg/L, respectively, compared to < 1.0 mg/L, and those for AD were 0.72 (95%CI 0.48–1.08), 1.76 (95%CI 1.08–2.89), and 1.61 (95%CI 1.11–2.35), for 1.0–1.9 mg/L, 2.0–2.9 mg/L, and ≥ 3.0 mg/L, respectively, compared to < 1.0 mg/L. Multivariable-adjusted ORs for all-cause dementia and for AD prevalence increased significantly with increasing serum hs-CRP levels (p for trend < 0.001 and p = 0.001, respectively). In addition, the multivariable-adjusted temporal cortex volume/estimated total intracranial volume ratio decreased significantly with increasing serum hs-CRP levels (< 1.0 mg/L 4.28%, 1.0–1.9 mg/L 4.27%, 2.0–2.9 mg/L 4.29%, ≥ 3.0 mg/L 4.21%; p for trend = 0.004). This study’s results suggest that elevated serum hs-CRP levels are associated with greater risk of presence of dementia, especially AD, and of temporal cortex atrophy in a community-dwelling Japanese older population.
KW - Alzheimer’s disease
KW - Dementia
KW - High-sensitivity C-reactive protein
KW - Inflammation
KW - Population-based study
UR - http://www.scopus.com/inward/record.url?scp=85189262336&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85189262336&partnerID=8YFLogxK
U2 - 10.1038/s41598-024-57922-1
DO - 10.1038/s41598-024-57922-1
M3 - Article
C2 - 38548879
AN - SCOPUS:85189262336
SN - 2045-2322
VL - 14
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 7374
ER -